This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Atopix Therapeutics Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Tony Pintus: Innovator in Pharmaceutical Chemistry
Introduction
Tony Pintus is a notable inventor based in Saint Jean de Linières, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes for compound preparation. His work is characterized by a focus on industrial-scale applications, which enhances the efficiency of drug development.
Latest Patents
Tony Pintus holds a patent for a process titled "Process for the preparation of (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid esters." This invention relates to a method for preparing a compound of formula (I), where R is either a Calkyl or benzyl group. The process involves reacting a compound of formula (II) with 2-quinoline carboxaldehyde. This innovative approach is suitable for use on an industrial scale, showcasing Pintus's commitment to practical applications in the pharmaceutical industry.
Career Highlights
Tony Pintus is currently associated with Atopix Therapeutics Limited, where he continues to advance his research and development efforts. His work at Atopix Therapeutics has positioned him as a key player in the pharmaceutical sector, contributing to the development of new therapeutic solutions.
Collaborations
Throughout his career, Tony Pintus has collaborated with esteemed colleagues such as Jacques Tonnel and Alain Burgos. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.
Conclusion
Tony Pintus is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug preparation processes. His innovative spirit and dedication to industrial applications continue to make a positive impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile